Bioinformatics Market is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0%
Bioinformatics Market is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0%. according to a new report by MarketsandMarkets™. The use of computer technology to comprehend and utilise biological and biomedical data effectively is known as bioinformatics. It is the field responsible for storing, analysing, and interpreting the Big Data gathered during clinical settings or as a result of life science investigations. The growth of the bioinformatics market is driven by the increasing public and private-sector funding for bioinformatics, growing demand for personalized medicine, increasing pharmaceutical and biotechnology RD expenditure, and decreasing cost of genome sequencing. However, the high cost of equipment is hindering the growth of this market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39
As the world witnesses unprecedented challenges in healthcare, from pandemics to personalized treatments, the role of bioinformatics has become more critical than ever before. [Your Company Name] has been at the forefront of harnessing the power of bioinformatics to unlock the potential of genomic data, enabling healthcare professionals, researchers, and pharmaceutical companies to make informed decisions and drive impactful outcomes.
Key Highlights and Innovations:
Advanced Genomic Analysis: MnM introduces cutting-edge algorithms and computational tools that empower researchers to extract valuable insights from complex genomic data.
Precision Medicine Solutions: Our state-of-the-art bioinformatics platforms enable healthcare providers to deliver personalized treatment plans based on a patient's unique genetic makeup.
Drug Discovery Optimization: Leveraging artificial intelligence and machine learning, MnM has developed innovative approaches to streamline drug discovery pipelines.
Data Security and Privacy: In an era of data-driven healthcare, safeguarding sensitive genomic information is paramount. MnM employs state-of-the-art encryption and privacy protocols to ensure the security of patient data, fostering trust among patients, healthcare providers, and researchers.
Browse Complete Report @ https://www.globenewswire.com/en/news-release/2023/04/14/2647115/0/en/Bioinformatics-Market-is-Expected-to-Reach-18-7-billion-MarketsandMarkets.html
Key Market Players
Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), DNASTAR (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.
Thermo Fisher Scientific, Inc. is the leading player in the bioinformatics market. The company mainly develops technologically advanced bioinformatics solutions to outstand its offerings. It invests into organic and inorganic growth strategies like acquisitions to strengthen its market presence.
North American bioinformatics market to dominate the market during the forecast period
North America dominated the bioinformatics market and is expected to grow at an 12.7% CAGR during the forecast period. The North America holds large share in the global bioinformatics market owing to factors such as government support for genomic research, presence of top key players in the region, reduced cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America.
Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=39
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.a
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
